Related Experiment Video

Updated: May 2, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K

miR-101 inhibits cell proliferation by targeting Rac1 in papillary thyroid carcinoma

Xiaojie Lin1, Hongyu Guan1, Hai Li1

  • 1Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China.

Biomedical Reports
|March 21, 2014
PubMed

Insights

MicroRNA-101 (miR-101) is downregulated in papillary thyroid carcinoma (PTC). Restoring miR-101 inhibits PTC cell growth by targeting Ras-related C3 botulinum toxin substrate 1 (Rac1).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) play a role in papillary thyroid carcinoma (PTC) progression.
  • The specific molecular mechanisms underlying miRNA involvement in PTC require further elucidation.

Purpose of the Study:

  • To investigate the role of microRNA-101 (miR-101) in PTC.
  • To determine if miR-101 targets Ras-related C3 botulinum toxin substrate 1 (Rac1) in PTC.

Main Methods:

  • Compared miR-101 expression in PTC tissues and adjacent normal tissues.
  • Restored miR-101 expression in the K1 PTC cell line to assess effects on cell proliferation.
  • Utilized computational algorithms and experimental validation to identify direct targets of miR-101.

Main Results:

  • miR-101 was significantly downregulated in PTC tissues compared to normal tissues.
  • Restoration of miR-101 expression inhibited proliferation of K1 PTC cells.
  • Rac1 was confirmed as a direct molecular target of miR-101 in K1 cells.

Conclusions:

  • miR-101 inhibits PTC growth by downregulating Rac1 expression.
  • This study enhances understanding of miRNA-modulated signaling in PTC.
  • Findings suggest potential therapeutic strategies targeting the miR-101/Rac1 axis in cancer treatment.
Keywords:
Ras-related C3 botulinum toxin substrate 1microRNA-101proliferationthyroid cancer

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.1K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

10.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K